Search Results

You are looking at 41 - 50 of 449 items for :

  • Refine by Access: Open Access content only x
Clear All
Open access

Jan Calissendorff and Henrik Falhammar

sustained in around 50–55% ( 1 ). Another option is surgery, which is often considered in recurrence of GD after medical therapy, in patients with large goitres, and when pregnancy is planned in the near future. The third possibility is treatment with

Open access

Leyre Lorente-Poch, Sílvia Rifà-Terricabras, Juan José Sancho, Danilo Torselli-Valladares, Sofia González-Ortiz, and Antonio Sitges-Serra

secondary hyperparathyroidism were excluded. All the procedures were performed by the same team of experienced endocrine surgeons at the Hospital Universitari del Mar in Barcelona, Spain, a referral center for Endocrine Surgery. Figure 1 Patient flow

Open access

Helle Døssing, Finn Noe Bennedbæk, and Laszlo Hegedüs

%) patients after LT. Nineteen patients (17 within 6 months and 2 patients after 36 months) had surgery after LT and the median follow-up for the remaining 91 patients was 45 months (range: 12–134). Figure 1 Algorithm for enrolment of study patients, in

Open access

Pablo Abellán-Galiana, Carmen Fajardo-Montañana, Pedro Riesgo-Suárez, Marcelino Pérez-Bermejo, Celia Ríos-Pérez, and José Gómez-Vela

Introduction Transsphenoidal surgery is the treatment of choice in Cushing’s disease (CD). Following removal of the pituitary adenoma, the remission rate varies between 25 and 100% (mean 77.8%, median 78.7%), and the recurrence rate ranges

Open access

R Walia, M Singla, K Vaiphei, S Kumar, and A Bhansali

virilization of external genitalia, prospects of restoring normal appearance of external genitalia and fertility and parent’s/patient’s preferences. Genital surgery is often required; however, the type and time of surgery are still debatable ( 5 ). Most of the

Open access

Daniel Bell, Julia Hale, Cara Go, Ben G Challis, Tilak Das, Brian Fish, and Ruth T Casey

treatment option for pHPT is parathyroid surgery (PTX), which is indicated according to international guidelines in those with symptomatic hypercalcaemia, renal/skeletal complications or a diagnosis of pHPT in patients less than 50 years ( 2 ). Some patients

Open access

Bernardo Maia, Leandro Kasuki, and Mônica R Gadelha

therapy and radiotherapy ( 4 , 6 , 7 ). Current treatments Surgical treatment Surgery is the gold standard treatment of acromegaly since it represents the only therapy capable of rapidly curing acromegaly ( 4 ). With experienced pituitary

Open access

Marlena Mueller, Fahim Ebrahimi, Emanuel Christ, Christian Andreas Nebiker, Philipp Schuetz, Beat Mueller, and Alexander Kutz

record featuring a procedure according to the CHOP-codes for parathyroidectomy (CHOP-codes shown in Fig. 1 ). Cases where the procedure parathyroidectomy was not classified as 'main treatment' were only included if no further surgery or major

Open access

G Giuffrida, F Ferraù, R Laudicella, O R Cotta, E Messina, F Granata, F F Angileri, A Vento, A Alibrandi, S Baldari, and S Cannavò

In this patient, macroprolactinoma was diagnosed when she was 42 years old and trans-sphenoidal surgery was performed after few months of ineffective high-dose cabergoline treatment. At the age of 55 years, serum PRL concentrations remarkably

Open access

Cecilia Follin and Sven Karlsson

diabetes and hypertension ( 3 , 4 ). The aims of treatment for acromegaly are to control/reduce tumour size, normalise GH and insulin-like growth factor 1 (IGF-1) levels and to improve comorbidities. Current treatments consist of surgery, medical therapy